WASHINGTON, D.C. (WTAP) - WV Senator Joe Manchin wants the FDA to adopt three policy changes from the Opioid Policy Steering Committee to reduce the availability of deadly opioids.
In a letter to the Commissioner of the Food and Drug Administration (FDA), Dr. Scott Gottlieb, Senator Manchin endorses the following FDA policy changes suggested by the Opioid Policy Steering Committee:
1. The FDA should require mandatory and continuing education for every healthcare provider who prescribes opioids.
2. The FDA should review every opioid product that is currently on the market to determine for each one if the risks outweigh the benefits.
3. For every new opioid medication the FDA approves, it should remove one or more older opioid medications from the market with a particular focus on opioids that are not crush-resistant and are more easily abused.
You can read Senator Manchin's entire letter at the link under the "Related Links" section of this story.